Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
SNY [NYSE]
Sanofi
Index- P/E26.83 EPS (ttm)1.90 Insider Own- Shs Outstand2.65B Perf Week-1.14%
Market Cap135.30B Forward P/E12.85 EPS next Y3.97 Insider Trans- Shs Float2.36B Perf Month-4.73%
Income5.10B PEG3.12 EPS next Q- Inst Own9.00% Short Float0.10% Perf Quarter0.00%
Sales44.41B P/S3.05 EPS this Y-25.60% Inst Trans0.06% Short Ratio2.46 Perf Half Y7.33%
Book/sh28.88 P/B1.76 EPS next Y12.64% ROA3.80% Target Price57.88 Perf Year-0.78%
Cash/sh2.14 P/C23.80 EPS next 5Y8.60% ROE6.70% 52W Range45.30 - 54.60 Perf YTD-1.51%
Dividend1.91 P/FCF- EPS past 5Y-1.10% ROI6.10% 52W High-6.11% Beta1.06
Dividend %3.75% Quick Ratio1.00 Sales past 5Y2.90% Gross Margin66.80% 52W Low13.16% ATR0.62
Employees112128 Current Ratio1.50 Sales Q/Q-2.80% Oper. Margin20.60% RSI (14)40.89 Volatility0.90% 1.01%
OptionableYes Debt/Eq0.26 EPS Q/Q9.80% Profit Margin11.60% Rel Volume1.96 Prev Close50.97
ShortableYes LT Debt/Eq0.19 EarningsFeb 09 BMO Payout44.70% Avg Volume947.17K Price51.27
Recom1.70 SMA20-1.59% SMA50-3.14% SMA2001.45% Volume785,229 Change0.58%
03-Aug-12Downgrade Standpoint Research Buy → Hold
11-Jan-11Downgrade Jefferies Buy → Hold
16-Nov-09Initiated Deutsche Securities Buy
14-Oct-09Upgrade UBS Sell → Neutral
28-Aug-09Upgrade JP Morgan Neutral → Overweight
29-Jun-09Downgrade JP Morgan Overweight → Neutral
28-May-09Upgrade Citigroup Hold → Buy
30-Apr-09Upgrade JP Morgan Neutral → Overweight
23-Mar-09Upgrade Jefferies & Co Underperform → Hold
17-Mar-09Initiated Credit Suisse Outperform
19-Feb-09Upgrade JP Morgan Underweight → Neutral
26-Jan-09Initiated Jefferies & Co Underperform
07-Nov-08Downgrade UBS Neutral → Sell
23-Sep-08Downgrade Credit Suisse Neutral → Underperform
24-Oct-07Initiated Bernstein Mkt Perform
06-Sep-07Initiated UBS Neutral
18-Jul-07Upgrade HSBC Securities Neutral → Overweight
14-Jun-07Reiterated Banc of America Sec Buy $50 → $48
14-Jun-07Downgrade JP Morgan Overweight → Neutral
14-Jun-07Downgrade HSBC Securities Overweight → Neutral
23-Jul-14 04:32PM  Biogen Stock's Tecfidera Embarrasses Wall Street at Motley Fool
22-Jul-14 05:02PM  Could This 1 Lawsuit Destroy Biogen Idec Stock? at Motley Fool
08:45AM  Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States PR Newswire
19-Jul-14 10:34AM  India Just Did What Millions of Americans Wish the U.S. Government Would Do at Motley Fool
07:23AM  Microsoft Layoffs Include an End to Original Video Production at Motley Fool
18-Jul-14 05:00PM  Salix-Pharming's Ruconest Gets FDA Nod for HAE Zacks
04:00PM  InterMune's (ITMN) Esbriet Gets Breakthrough Designation Zacks
17-Jul-14 04:02PM  3 Stocks Pushing The Health Care Sector Lower at TheStreet
04:02PM  3 Stocks Pushing The Drugs Industry Lower at TheStreet
16-Jul-14 11:07AM  How Will Sanofi (SNY) Stock Be Affected By Possible Sale Of Mature Drug Portfolio? at TheStreet
15-Jul-14 10:00AM  Peregrine Pharmaceuticals' Q4 Loss Narrower than Expected Zacks
14-Jul-14 04:20PM  Sanofi's Dengue Vaccine Data Published Zacks
13-Jul-14 12:06PM  2.5 Billion People Threatened by This Disease: How We're Fighting Back at Motley Fool
12-Jul-14 01:46AM  [$$] 13D Filings at Barrons.com
10-Jul-14 03:30PM  Sanofi/Regeneron Announce Encouraging Dupilumab Data Zacks
01:46PM  Regeneron's Dupilumab Drug Headed For Phase Three Tests at Investor's Business Daily
10:07AM  Regeneron Picked a Heck of a Day to Announce Good News at Barrons.com
08:20AM  The Zacks Analyst Blog Highlights: Regado Biosciences, Jazz Pharmaceuticals, Regeneron Pharmaceuticals, Sanofi and Amgen Zacks
07:48AM  Early movers: UNH, BAC, IBM, COST, LL, WDFC & more at CNBC
09-Jul-14 09:04PM  Regeneron, Sanofi Drug Holds Up in Eczema Study at Motley Fool
05:00PM  Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis PR Newswire
11:10AM  Anacor's Kerydin Gets FDA Nod for Onychomycosis Zacks
10:09AM  Sanofi Is Buying Shares Of Regeneron - You Should Too at Seeking Alpha
09:00AM  Wednesdays Top Biotech Stories: Celgene, AbbVie, Shire, and Sanofi at Motley Fool
08:15AM  Biotech Stock Roundup: Regado Plunges on Study Update, Jazz Gains on Product Acquisition Deal Zacks
08-Jul-14 05:40PM  Sanofi's Basal Insulin Candidate Under FDA Review Zacks
02:14PM  Why Eli Lilly (LLY) Stock Is Down This Afternoon at TheStreet
11:17AM  Is Now The Time To Buy Merrimack Pharmaceuticals? at Seeking Alpha
09:26AM  How Flu Tried To Steal The World Cup's Thunder at Forbes
08:01AM  FDA Accepts Sanofi's New Drug Application for Basal Insulin Toujeo┬« PR Newswire
07:45AM  [video] Steps to improve long-term health: Sanofi CEO at CNBC
07-Jul-14 05:02PM  Growth and Dividends: Europe's Best Pharma Stock at Motley Fool
03:45PM  Glaxo's Two Cancer Drugs Get EU Nod Zacks
10:29AM  Is Europe Igniting Eli Lilly's Comeback? at Motley Fool
10:22AM  3 Reasons Why You Should Care About Narendra Modi at Seeking Alpha
06-Jul-14 03:00PM  3 Stocks That Soared Stupendously This Week at Motley Fool
03-Jul-14 12:36PM  Sanofi and CureVac Ink Vaccine Deal Zacks
11:00AM  Impax Acquires Generic Products from Actavis Zacks
02-Jul-14 10:30AM  Regeneron Shares Jump as Sanofi Increases Stake Zacks
09:47AM  JuniorSTAR insulin pen designed to help young people living with diabetes take greater control of their lives CNW Group
01-Jul-14 07:52PM  Danger Ahead for Investors in this $8 Billion Blockbuster at Motley Fool
05:19PM  Unstoppable: S&P 500 Hits Record High as Regeneron, Netflix Surge; Dow Nears 17,000 at Barrons.com
05:19PM  Salix Pharma Hits A New High On Bullish Clinical-Trial Data Investor's Business Daily
05:11PM  ESC Hot Lines: First Real Data On Promising Novartis Heart Failure Drug at Forbes
05:08PM  Is this Biogen's Biggest Risk? at Motley Fool
04:08PM  First-ever kosher prescription medication at CNBC
03:45PM  Amicus Up on Migalastat Study Update Zacks
02:35PM  Dow Nears 17,000, S&P 500 Hits Record High as Regeneron, Netflix Surge at Barrons.com
01:12PM  Regeneron Rises As Sanofi Raises Stake In Biotech at Investor's Business Daily
01:09PM  Why Regeneron Pharmaceuticals (REGN) Stock Is Soaring Today at TheStreet
09:00AM  CureVac Signs an Exclusive License Agreement with Sanofi Pasteur to Develop and Commercialize an mRNA-based Prophylactic Vaccine PR Newswire
30-Jun-14 02:02PM  MannKind Stock: Afrezza Approved at Last, But Will Sales Disappoint? at Motley Fool
12:50PM  Eli Lilly & Boehringer's Insulin Copy Gets Positive EU Opinion Zacks
08:10AM  Genzyme announces Lemtrada approval in Argentina at theflyonthewall.com
08:00AM  Genzymes Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis Business Wire
27-Jun-14 12:00PM  Is Novartis' Dividend Safe? at Motley Fool
12:00PM  Is Novartis' Dividend Safe?
11:59AM  Android L Hands-on Review: Has Google Done Enough To Beat Apple's iOS 8?
24-Jun-14 01:11AM  Is Sanofi's Dividend Safe? at Motley Fool
01:11AM  Is Sanofi's Dividend Safe?
23-Jun-14 04:32PM  Sanofi: Toujeo Is Not The Ace In Its Deck at Seeking Alpha
04:32PM  Sanofi: Toujeo Is Not The Ace In Its Deck
03:45PM  Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights Zacks
03:45PM  Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights
12:59PM  Can Cancer Patients Really Get 'Drunk' From Docetaxel? at Forbes
12:59PM  Can Cancer Patients Really Get 'Drunk' From Docetaxel?
22-Jun-14 10:13PM  A Tribute To Healthcare's First Transparent Pricing Pioneer at Forbes
10:13PM  A Tribute To Healthcare's First Transparent Pricing Pioneer
20-Jun-14 06:24PM  Who Will Win This $45 Billion Market? at Motley Fool
06:24PM  Who Will Win This $45 Billion Market?
11:38AM  Merrimack Pharmaceuticals: The Sleeping Giant Of Cancer Care at Seeking Alpha
11:38AM  Merrimack Pharmaceuticals: The Sleeping Giant Of Cancer Care
11:34AM  Midday movers: Alstom, CarMax, Sprint & More at CNBC
11:34AM  Midday movers: Alstom, CarMax, Sprint & More
09:08AM  Today's Top Biotech Stocks to Watch: AbbVie, Merrimack Pharmaceuticals, and Shire plc at Motley Fool
09:08AM  Today's Top Biotech Stocks to Watch: AbbVie, Merrimack Pharmaceuticals, and Shire plc
19-Jun-14 07:52PM  Why Merrimack Pharmaceuticals Inc. Shares Plunged in After Hours at Motley Fool
07:52PM  Why Merrimack Pharmaceuticals Inc. Shares Plunged in After Hours
05:15PM  Protalix Drug in Phase IIa Study for Gaucher Disease Zacks
05:15PM  Protalix Drug in Phase IIa Study for Gaucher Disease
01:40AM  IPO Preview: Ardelyx at Seeking Alpha
01:40AM  IPO Preview: Ardelyx
18-Jun-14 03:51PM  Is Pfizer a Safe Investment? at Wall St. Cheat Sheet
03:51PM  Is Pfizer a Safe Investment?
01:50PM  Medtronic, Sanofi to Form Strategic Diabetes Alliance Zacks
01:50PM  Medtronic, Sanofi to Form Strategic Diabetes Alliance
01:03PM  3 Stocks Pulling The Drugs Industry Downward at TheStreet
01:03PM  3 Stocks Pulling The Drugs Industry Downward
12:19PM  Emerging Markets Offer A New Channel Of Demand For Pharmaceutical Products at Forbes
17-Jun-14 02:33PM  Time To Buy Aastrom Biosciences at Seeking Alpha
09:52AM  CrowdGather: Diversified Play on High-Growth Social Gaming Accesswire
16-Jun-14 06:57PM  Will ghoulish investments pay off? at CNBC
05:32PM  3 Undervalued Amgen Growth Opportunities to Watch at Motley Fool
03:30PM  Sanofi's Diabetes Portfolio in Focus at American Diabetes Association Sessions Zacks
01:38PM  TEENs Study Shows Achieving Target Blood Sugar Levels is Associated with Better Quality of Life for Young People with Type 1 Diabetes CNW Group
01:32PM  TEENs Study Shows Achieving Target Blood Sugar Levels is Associated with Better Quality of Life for Young People with Type 1 Diabetes PR Newswire
12:33PM  Sanofi's Lyxumia(R) (lixisenatide) Showed More Pronounced After-Test-Meal Blood Sugar Lowering Than Liraglutide When Both Were Added to Insulin Glargine PR Newswire
10:10AM  Eli Lilly Impresses at American Diabetes Association Sessions Zacks
09:44AM  Are Investors Overestimating The Market For MannKind's Afrezza? at Seeking Alpha
15-Jun-14 01:31PM  Sanofi presents results of study comparing Lyxumia to liraglutide at theflyonthewall.com
Sanofi researches, develops, manufactures, and markets healthcare products. The company operates in three segments: Pharmaceuticals, Human Vaccines, and Animal Health. Its products include Lantus and Apidra analogs of human insulin; Insuman human insulin solutions and suspensions; Amaryl, a sulfonylurea; BGStar, iBGStar, and MyStar Extra blood glucose meters; enzyme replacement therapies, such as Cerezyme for Gaucher disease, Fabrazyme for Fabry, and Myozyme/Lumizyme for Pompe disease; Aldurazyme, for mucopolysaccharidosis Type I; Aubagio, a immunomodulator for multiple sclerosis; Taxotere, a taxane derivative for cancers; Eloxatine for colorectal cancer; and Jevtana for prostate cancer. The company's products also comprise thrombosis medicines, such as Plavix anti-platelet agent for atherothrombotic conditions and Lovenox to prevent and treat deep vein thrombosis; and cardiovascular medicines, including Multaq anti-arrhythmic agent and Aprovel/CoAprovel for hypertension treatments. It also offers Renagel/Renvela for patients with chronic kidney disease on dialysis to treat high phosphorus levels; Synvisc and Synvisc-One viscosupplements to treat pain associated with osteoarthritis; and pediatric and influenza, adult and adolescent booster, meningitis and pneumonia, and travel and endemics vaccines. In addition, the company provides pharmaceuticals and vaccines used by veterinarians, farmers, and pet owners; consumer health care products; and generic medicines. Sanofi distributes its products through its sales force, as well as through physicians, pharmacies, hospitals, distributors, veterinaries, chemists, and wholesalers. It has strategic alliances with Bristol-Myers Squibb, Regeneron, Warner Chilcott, Regulus Therapeutics Inc., and Medtronic, Inc., as well as a strategic collaboration with UCB S.A. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1970 and is headquartered in Paris, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanofi10% OwnerJul 15Buy314.92129,10040,656,17622,204,841Jul 17 05:50 PM
Sanofi10% OwnerJul 14Buy318.18150,00047,726,79722,075,741Jul 15 05:45 PM
Sanofi10% OwnerJul 11Buy315.41150,00047,311,83621,925,741Jul 15 05:45 PM
Sanofi10% OwnerJul 10Buy311.08175,00054,439,07321,775,741Jul 14 05:46 PM
Sanofi10% OwnerJul 09Buy308.27195,00060,112,31121,600,741Jul 10 05:45 PM
Sanofi10% OwnerJul 08Buy311.67153,00047,685,74321,405,741Jul 10 05:45 PM
Sanofi10% OwnerJul 07Buy312.90256,70080,320,79521,252,741Jul 08 05:42 PM
Sanofi10% OwnerJul 03Buy311.02100,00031,101,94620,996,041Jul 08 05:42 PM
Sanofi10% OwnerJul 02Buy307.25212,40065,259,55220,896,041Jul 03 06:00 PM
Sanofi10% OwnerJul 01Buy300.20212,40063,761,42120,683,641Jul 03 05:46 PM
Sanofi10% OwnerJun 30Buy282.54212,40060,010,47920,471,241Jul 01 05:39 PM
Sanofi10% OwnerJun 27Buy275.3850,00013,769,09220,258,841Jul 01 05:39 PM
Sanofi10% OwnerMay 19Buy300.04190,75157,233,71620,208,841May 21 05:02 PM
Sanofi10% OwnerMar 28Buy306.73306,94594,149,58320,018,090Mar 31 06:22 PM
Sanofi10% OwnerMar 27Buy311.01306,94595,463,96319,711,145Mar 31 06:21 PM
Sanofi10% OwnerMar 24Buy307.91306,94594,511,73418,790,310Mar 25 06:11 PM
Sanofi10% OwnerMar 21Buy321.22305,11598,008,22218,483,365Mar 25 06:10 PM
Sanofi10% OwnerMar 20Buy328.4157,95719,033,51118,178,250Mar 21 06:21 PM
Sanofi10% OwnerMar 19Buy327.899,7463,195,65118,120,293Mar 21 06:21 PM
Sanofi10% OwnerMar 17Buy328.5560,12819,755,23418,110,547Mar 18 06:58 PM
Sanofi10% OwnerMar 14Buy328.3655,58318,251,21518,050,419Mar 18 06:58 PM
Sanofi10% OwnerMar 12Buy334.69220,99573,964,41217,994,836Mar 14 05:11 PM
Sanofi10% OwnerMar 11Buy332.26180,71060,043,33617,773,841Mar 12 05:36 PM
Sanofi10% OwnerMar 10Buy328.73199,82265,687,43517,593,131Mar 12 05:36 PM
Sanofi10% OwnerMar 07Buy332.51241,81880,405,73317,393,309Mar 10 09:52 PM
Sanofi10% OwnerMar 07Buy316.2069,87322,093,65517,151,491Mar 10 09:51 PM
Sanofi10% OwnerMar 06Buy339.6080,40427,305,54617,081,618Mar 10 09:51 PM
Sanofi10% OwnerMar 03Buy338.12251,59485,070,11817,001,214Mar 05 08:36 PM
Sanofi10% OwnerFeb 07Buy287.3421,9866,317,45516,749,620Feb 10 06:46 PM
Sanofi10% OwnerFeb 06Buy286.70146,52542,008,39016,727,634Feb 10 06:46 PM
Sanofi10% OwnerFeb 05Buy282.00206,97858,367,10716,581,109Feb 06 07:30 PM
Sanofi10% OwnerFeb 04Buy286.44190,28654,504,78916,374,131Feb 06 07:30 PM
Sanofi10% OwnerFeb 03Buy283.46198,05856,141,71916,183,845Feb 04 07:11 PM
Sanofi10% OwnerJan 31Buy289.6610,9143,161,38315,985,787Feb 04 07:11 PM
Sanofi10% OwnerJan 28Buy278.5483,23523,184,32115,974,873Jan 29 08:20 AM
Sanofi10% OwnerJan 27Buy272.9674,68520,386,04415,891,638Jan 29 08:20 AM